GlassScriptPhysician profile
Marvin Joseph Morrison
NPI 1043599004
$988.12
in general payments reported to CMS, 2019-2025
14 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $146 · 2023: $263 · 2024: $86.50 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $600.87 | 2021-2025 | |
| Gilead Sciences, INC. | $68.64 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $58.72 | 2025 | Airsupra, Breztri |
| Alkermes, INC. | $48.92 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.55 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $24.91 | 2025 | |
| Viatris Specialty LLC | $24.89 | 2025 | Yupelri |
| Indivior INC. | $24.18 | 2024 | Sublocade |
| Pfizer INC. | $22.41 | 2023 | |
| Harmony Biosciences LLC | $18.12 | 2025 | |
| Mylan Specialty L.P. | $15.71 | 2021 | |
| Braeburn INC. | $14.16 | 2025 | Brixadi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.06 | 2021 | |
| Organon LLC | $4.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.